COP vs TMO: Which Is the Better Buy?
Side-by-side comparison of ConocoPhillips and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-08.
ConocoPhillips · Energy
$108.44
-21.6% upside to fair value
Grade D
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+7.2%).
COP trades at a lower forward P/E
(18.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
COP |
TMO |
| Current Price |
$108.44 |
$464.61 |
| Fair Value Estimate |
$85.04 |
$498.27 |
| Upside to Fair Value |
-21.6%
|
+7.2%
|
| Market Cap |
$132.1B |
$172.7B |
| Forward P/E |
18.4x
|
25.2x
|
| EV / EBITDA |
6.1x
|
19.1x
|
| Price / Sales |
2.3x
|
3.8x
|
| Price / FCF |
8.6x
|
25.6x
|
| Revenue Growth YoY |
-2.5%
|
+6.2%
|
| Gross Margin |
29.2%
|
39.4%
|
| Operating Margin |
18.3%
|
17.8%
|
| Return on Equity |
11.3%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
11.64%
|
3.91%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
ConocoPhillips is a major player in the Energy sector focused on Oil & Gas Exploration & Production. The company demonstrates medium business quality with a stable competitive position but faces earnings pressure as reflected in a 23.4% decline in earnings and a 2.5% decline in revenue in the most recent quarter year-over-year. Despite a solid ROE of 11.3% and attractive margins (gross margin 29.…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
COP |
TMO |
| Zone Low |
$63.78 |
$373.70 |
| Zone High |
$72.28 |
$423.53 |
| In Buy Zone? |
No
|
No
|